Protagonist Therapeutics, Inc Quarterly Common Stock, Shares, Issued from Q4 2015 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Protagonist Therapeutics, Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2015 to Q3 2024.
  • Protagonist Therapeutics, Inc Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 59.5M shares, a 3.25% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 59.5M +1.87M +3.25% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 58.8M +1.27M +2.21% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 58.6M +7.16M +13.9% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 57.7M +8.37M +17% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 57.6M +8.45M +17.2% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 57.5M +8.81M +18.1% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 51.4M +2.89M +5.95% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 49.3M +1.5M +3.14% Dec 31, 2022 10-K 2024-02-27
Q3 2022 49.2M +1.53M +3.2% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 48.7M +1.16M +2.44% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 48.6M +4.61M +10.5% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 47.8M +4.09M +9.36% Dec 31, 2021 10-K 2023-03-15
Q3 2021 47.7M +10.4M +27.8% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 47.5M +10.7M +29.1% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 43.9M +16.5M +60.2% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 43.7M +16.5M +60.7% Dec 31, 2020 10-K 2022-02-28
Q3 2020 37.3M +10.1M +37.2% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 36.8M +11.8M +47.4% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 27.4M +4.04M +17.3% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 27.2M +4.03M +17.4% Dec 31, 2019 10-K 2021-03-10
Q3 2019 27.2M +3.07M +12.7% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 25M +3.75M +17.7% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 23.4M +2.23M +10.5% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 23.2M +2.1M +9.95% Dec 31, 2018 10-K 2020-03-10
Q3 2018 24.1M +7.19M +42.5% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 21.2M +4.32M +25.6% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 21.2M +4.33M +25.7% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 21.1M +4.37M +26.1% Dec 31, 2017 10-K 2019-03-12
Q3 2017 16.9M +230K +1.37% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 16.9M +16.5M +4302% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 16.8M Mar 31, 2017 10-Q 2017-05-10
Q4 2016 16.7M +16.4M +6039% Dec 31, 2016 10-K 2018-03-07
Q3 2016 16.7M Sep 30, 2016 10-Q 2016-11-14
Q2 2016 384K Jun 30, 2016 10-Q 2016-09-15
Q4 2015 272K Dec 31, 2015 10-K 2017-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.